PeruPeru is Latin America's fastest-growing pharmaceutical market, with a reform-driven regulatory environment under DIGEMID and a population of 33 million creating real demand for imported life-sciences products. Taevas provides end-to-end market entry suppo
Select an industry to see regulatory pathways, services, and how Taevas supports your Peru market entry.
Direccion General de Medicamentos, Insumos y Drogas (DIGEMID)
Peru's medical device sector is expanding rapidly, driven by public hospital modernization programs and rising private healthcare investment across Lima and regional cities. DIGEMID classifies devices into four risk classes and requires mandatory product registration and import authorization before market entry. Taevas coordinates the full registration lifecycle — from technical dossier preparation to post-market surveillance — ensuring your device reaches Peruvian clinicians without delays.
All medical devices sold in Peru must obtain a Registro Sanitario from DIGEMID. Taevas prepares and submits the complete technical dossier aligned with DIGEMID's classification framework and Andean Community Decision 706 requirements.
DIGEMID classifies devices from Class I (low risk) to Class IV (high risk) based on intended use and patient contact. Taevas conducts pre-submission classification reviews to determine the correct pathway and avoid reclassification delays.
Foreign manufacturers must secure an import authorization from DIGEMID prior to each shipment. Taevas manages the documentation, customs coordination, and DIGEMID liaison to ensure compliant clearance at Callao port.
DIGEMID requires ongoing adverse event reporting and periodic safety updates for registered devices. Taevas maintains a local vigilance system, files incident reports, and manages renewals to keep your registration in continuous good standing.
Taevas combines deep DIGEMID regulatory expertise with established commercial networks across Peru's public and private healthcare sectors, giving international life-sciences brands a proven, accountable partner from registration to revenue.
Our Lima-based regulatory team has managed hundreds of Registro Sanitario submissions across medical devices, pharmaceuticals, and cosmetics, with a track record of on-time approvals and zero critical deficiencies. We know DIGEMID's processes, reviewers, and timelines intimately.
Taevas operates across all 25 Peruvian regions — from Lima's private hospital network to regional EsSalud facilities in Arequipa, Trujillo, and Cusco — ensuring your product reaches every addressable market segment nationwide.
Our pre-submission review process, parallel-track dossier preparation, and active DIGEMID liaison reduce typical registration timelines by up to 30%, getting your product to Peruvian patients and consumers faster than going it alone.
Taevas maintains active relationships with Peru's leading pharmaceutical distributors, medical device importers, and specialty beauty and supplement channels, enabling rapid commercial activation without the months-long partner search.
We have mapped and engaged key opinion leaders across Peru's major therapeutic areas and device specialties — including surgeons, pharmacists, nutritionists, and dermatologists — building the clinical and consumer advocacy your brand needs to grow.
From the first regulatory submission to ongoing post-market compliance, distributor performance management, and marketing execution, Taevas is your single accountable partner — eliminating the coordination risk of managing multiple local vendors.
Whether you are preparing your first DIGEMID submission or scaling an existing product portfolio across Peru's regions, Taevas provides the regulatory expertise, commercial networks, and in-country execution to make your market entry successful.